drugset / Trial / NCT05608980

0.01% Hypochlorous Acid in the Treatment of Blepharitis

NCT05608980

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.

Timeline

Start
2022-07-01
Primary completion
2022-12-01
Completion
2023-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hypochlorous acid Other / unclassified 0.01 % Topical

Indications